secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2025-09-09T23:59:59+00:00
Accession:  0001193125-25-198816
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics secures up to $6.0M in prepaid advances from Yorkville; second $1.0M tranche drawn
--------------------------------------------------------------------------------

- Entered Pre-Paid Advance Agreement with Yorkville for up to $6.0M over 12 months; initial $1.0M advance closed July 29, 2025.
- As of Sept 8, 2025, 479,036 shares issued at avg $1.06 to Yorkville, offsetting $500K of initial advance.
- Second $1.0M advance drawn on Sept 8, 2025 ($0.95M net proceeds); Yorkville may demand stock to reduce balance.
- Advances have 8% interest (18% default), 12-month maturity; each advance sold at 95% of face amount.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525198816/0001193125-25-198816-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525198816/d47459d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-198816

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer